ADG206

· Adagene Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADG206, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors [Phase 1]